Peer-influenced content. Sources you trust. No registration required. This is HCN.
Journal of Women’s Health
A clinical review outlines how OBGYNs can integrate GLP-1 receptor agonist therapy into obesity care for women of reproductive age, with attention to fertility, contraception, and adherence.
Obstetrics & Gynecology May 20th 2026
ReachMD
Paracervical block consistently reduces pain during IUD insertion in vaginally nulliparous patients, while NSAIDs, misoprostol, and nitrous oxide show no clinical benefit across randomized trials.
Family Medicine/General Practice May 6th 2026
Medical Professionals Reference (MPR)
Foundayo will be available via LillyDirect beginning April 6, with widespread availability through retail pharmacies and telehealth providers occurring soon after.
Endocrinology, Diabetes, Metabolism April 8th 2026
“The updated label for Nexplanon reflects the diversity of patients we see every day, women throughout their reproductive ages, those seeking a long-acting option of up to 5 years, those who prefer birth control that goes in the arm rather than the uterus, and women across a wide range of BMIs,” said Anita Nelson, MD, Professor, Obstetrics and Gynecology at Western University of Health Sciences.
Endocrinology, Diabetes, Metabolism January 27th 2026
MDLinx
Refresh yourself on these six sex myths to help improve communication about sexual health with your patients.
Family Medicine/General Practice January 27th 2026
Conexiant
As modest reductions in weight can improve fertility, the risk of unintended pregnancy is significant if effective contraception is not used.
Endocrinology, Diabetes, Metabolism September 16th 2025